RXST
RxSight Inc

468
Mkt Cap
$403.35M
Volume
794,173.00
52W High
$34.71
52W Low
$6.32
PE Ratio
-11.17
RXST Fundamentals
Price
$9.66
Prev Close
$9.81
Open
$9.79
50D MA
$10.80
Beta
1.59
Avg. Volume
800,389.00
EPS (Annual)
-$0.7064
P/B
1.46
Rev/Employee
$280,977.91
Loading...
Loading...
News
all
press releases
Expert Outlook: RxSight Through The Eyes Of 5 Analysts
read more...
Benzinga·4h ago
News Placeholder
More News
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc...
PR Newswire·5d ago
News Placeholder
RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock?
RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·8d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc...
PR Newswire·12d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc...
PR Newswire·19d ago
News Placeholder
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of "Reduce" from Brokerages
Shares of RxSight, Inc. (NASDAQ:RXST - Get Free Report) have earned an average rating of "Reduce" from the thirteen brokerages that are currently covering the company, MarketBeat Ratings reports...
MarketBeat·20d ago
News Placeholder
RxSight (NASDAQ:RXST) Shares Gap Down - Should You Sell?
RxSight (NASDAQ:RXST) Shares Gap Down - Time to Sell...
MarketBeat·28d ago
News Placeholder
RxSight CFO Shelley Thunen To Transition From Role; Successor Search Underway
(RTTNews) - RxSight, Inc. (RXST), an ophthalmic medical device company, on Tuesday announced that Chief Financial Officer Shelley Thunen is transitioning from her role...
Nasdaq News: Markets·29d ago
News Placeholder
Thrivent Financial for Lutherans Lowers Holdings in RxSight, Inc. $RXST
Thrivent Financial for Lutherans decreased its holdings in RxSight, Inc. (NASDAQ:RXST - Free Report) by 30.9% in the second quarter, according to the company in its most recent disclosure with the...
MarketBeat·1mo ago
News Placeholder
Divisadero Street Capital Management LP Has $2.85 Million Stock Position in RxSight, Inc. $RXST
Divisadero Street Capital Management LP reduced its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 75.3% during the 2nd quarter, according to its most recent 13F filing with the Securities...
MarketBeat·1mo ago
<
1
2
...
>

Latest RXST News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.